Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss? That’s the potential promise of a new class of biomark ...

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Add Yahoo as a preferred source to see more of our stories on Google. "No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat ...

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats that consumers should understand.

For years, it has been one of the most tantalizing ideas in medicine: One day, a simple blood test will detect nascent cancers - allowing doctors to intervene when tumors may be easier to treat. A ...

Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...

Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...